Symbol="APRE"
AssetType="Common Stock"
Name="Aprea Therapeutics Inc"
Description="Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies that reactivate the mutant p53 tumor suppressor protein. The company is headquartered in Boston, Massachusetts."
CIK="1781983"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="535 BOYLSTON STREET, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="10777900"
EBITDA="-33917800"
PERatio="None"
PEGRatio="None"
BookValue="7.1"
DividendPerShare="0"
DividendYield="0"
EPS="-59.57"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.537"
ReturnOnEquityTTM="-2.823"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-59.57"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.035"
EVToRevenue="-"
EVToEBITDA="0.129"
Beta="0.166"
num_52WeekHigh="25.8"
num_52WeekLow="0.474"
num_50DayMovingAverage="3.562"
num_200DayMovingAverage="7.43"
SharesOutstanding="3731600"
DividendDate="None"
ExDividendDate="None"
symbol="APRE"
open="2.85"
high="2.96"
low="2.83"
price="2.89"
volume="13048.00"
latest_trading_day="2023-07-10"
previous_close="2.89"
change="-0.00"
change_percent="-0.0900%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="40"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="60"
Volume_recent_avg="15433"
Change_recent_avg="-0.06"
Delta_recent_avg="0.29"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-1.45"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="60"
Aroon_momentum_negative="40"
image_negative_thumbnail_id_1="101"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0075.jpeg"
image_negative_thumbnail_id_2="1162"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0196.jpeg"
image_neutral_thumbnail_id_1="567"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="995"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0157.jpeg"
image_positive_thumbnail_id_2="651"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0057.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
